QR-Code

Recent Progress in the Development of Opaganib for the Treatment of Covid-19

Charles D Smith,1 Lynn W Maines,1 Staci N Keller,1 Vered Katz Ben-Yair,2 Reza Fathi,2 Terry F Plasse,2 Mark L Levitt2 1Apogee Biotechnology Corporation, Hummelstown, PA, USA; 2RedHill Biopharma LTD, Tel Aviv, IsraelCorrespondence: Charles D Smith, Apogee Biotechnology Corporation, 1214 Research Blvd...

Ausführliche Beschreibung

Gespeichert in:
Hauptverfasser: Smith CD, Maines LW, Keller SN, Katz Ben-Yair V, Fathi R, Plasse TF, Levitt ML
Format: Artigo
Sprache:Inglês
Veröffentlicht: Dove Medical Press 2022-07-01
Schriftenreihe:Drug Design, Development and Therapy
Schlagworte:
opaganib
abc294640
sphingolipid
sphingosine kinase
dihydroceramide desaturase
glucosylceramide synthase
Online-Zugang:https://www.dovepress.com/recent-progress-in-the-development-of-opaganib-for-the-treatment-of-co-peer-reviewed-fulltext-article-DDDT
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!

Ähnliche Einträge